Alan T. Hirsch, MD, FACC, FAHA, FSVM

Philosophy of Care:

All patients deserve the opportunity to prevent illness and thus preserve their health; to truly know and understand their diagnosis; to be familiar with their treatment options, so that they can fully participate in health decisions; and to be empowered to establish a team of clinicians that are unified in protecting their long-term health. These promises should be fulfilled between patient and physician in a relationship characterized by empathy and trust. 

Medical Title:

Academic Appointments:



Clinical Interests:

Languages Spoken:


Board Certifications:

Mpls. St. Paul Magazine "Top Doctor" - (2012, 2014)

John Harvard Scholar, 1974
Magna Cum Laude academic honors, Harvard College, 1976
Summa with Highest Honors, Senior Thesis, Harvard College, 1976
American College of Chest Physicians Fellowship Award, 1987-1988
Charles River Foundation Animal Research Award, 1989
University of Minnesota Family Practice Teaching Recognition Award, 1996
Educational Achievement Award, Department of Medicine, University of Minnesota, 1998
Clinical Excellence Award, CSU Board of Governors, University of Minnesota, 2000
Community Partners Recognition Award, University of Minnesota School of Public Health, 2004
“Master of the Society for Vascular Medicine”, 2007
“President’s Award” of the Vascular Disease Foundation, 2008

“President’s Award for Vision” of the Vascular Disease Foundation, 2009

Public Book: “100 Questions and Answers About Peripheral Artery Disease” (see:
Academic Manuscripts:
1.       Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW, Krook SH, Hunninghake DB, Comerota AJ, Walsh ME, McDermott MM, Hiatt WR. Peripheral arterial disease detection, awareness, and treatment in primary care. J Am Med Assoc 2001;286:1317-1324.
2.       Stewart KJ, Hiatt WR, Regensteiner JG, Hirsch AT. Medical progress: exercise training for claudication. New Engl J Med 2002; 347(24):1941-1951.
3.       Creager MA, Hirsch AT, Cooke JP, Olin JW, Jaff MR, Rooke T, Halperin JL. On behalf of the Working Group on Fellowship Training in Vascular Medicine. Postgraduate training in vascular medicine: proposed requirements and standards. Vascular Medicine  2003;8:47-52.
4.       Hirsch AT, Gloviczki P, Drooz A, Lovell M, and Creager MA on behalf of the Trustees of the Vascular Disease Foundation. The mandate for creation of a national PAD public awareness program: an opportunity to improve cardiovascular health. J Vasc Surg 2004;39:474-481 (co-published in: J Vasc Endovasc Surg; J Vasc Nursing; J Vasc Interventional Radiol; Vascular Medicine ; International Angiology; Angiology; Endovascular Today)
5.       Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients with Peripheral Arterial Disease [Lower Extremity, renal, Mesenteric, and Abdominal Aortic]). Circulation 2006;113:1474-1547; and J Am Coll Cardiol, 2006;47:1239-1312. 
6.       Hirsch AT. The treatment of peripheral arterial disease - extending “Intervention” to “Therapeutic Choice”. New England J Med 2006;354(18):1944-1947.
7.       Hirsch AT. Critical limb ischemia and stem cell research. Anchoring hope with informed adverse event reporting. Circulation. 2006;114:2581-2583.
8.       Hirsch AT, Murphy TP, Lovell MB, Twillman G, Treat-Jacobson D, Harwood E, Mohler ER, Creager MA, Hobson RW, Robertson RM, Howard WJ, Criqui MH. Gaps in public knowledge of peripheral arterial disease: the First National PAD Public Awareness Survey. Circulation 2007;116(18):2086-2094.
9.       Murphy TP, Hirsch AT, Ricotta JJ, Cutlip DE, Mohler E, Regensteiner JG, Comerota AJ, Cohen DJ, on behalf of the CLEVER Steering Committee. The National Institutes of Health CLEVER Study (Claudication: Exercise Vs. Endoluminal Revascularization): Rationale and Methods. J Vasc Surg 2008;47(6):1356-1363.PMCID: PMC2519609
10.   Hirsch AT, Hartman L, Town RJ, Virnig BA. National healthcare costs of peripheral arterial disease in the Medicare population. Vasc Med 2008;;13(3):209-215.
11.   Mahoney EM. Wang K, Keo HH, Duval S, Smolderan K, Cohen D, Steg PG, Bhatt DL, and Hirsch AT, on behalf of the REACH Registry Investigators. Annual vascular hospitalization rates and costs in patients with peripheral arterial disease in the United States. Circulation: Quality and Outcomes 2010, In press.

Hennrikus D, Joseph A, Lando HA, Duval S, Kodl M, Ukestad L, Hirsch AT. Effectiveness of a smoking cessation program for peripheral artery disease patients: A randomized controlled trial.  J Amer Coll Cardiol 2010;56;2105-2112.

Discrimination is Against the Law. We comply with applicable Federal civil rights laws. We do not discriminate against, exclude or treat people differently because of race, color, national origin, age, disability or sex.
 Visit Other Fairview Sites 
(c) 2017 Fairview Health Services. All rights reserved.